A case of severe refractory chronic urticaria: A novel method for evaluation and treatment

Allergy and Asthma Proceedings

Volumn 30, Issue 3, 2009, Pages 333-337

  Otto, Hans F ^a   Calabria, Christopher W ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Autologous sweat skin test; Cholinergic urticaria; Omalizumab; Pilocarpine iontophoresis; Sweat collection; Urticaria; Xolair

Indexed keywords

HISTAMINE; IMMUNOGLOBULIN E; OMALIZUMAB; PILOCARPINE; ANTIALLERGIC AGENT; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; MUSCARINIC AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC URTICARIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; HUMAN; QUALITY OF LIFE; SKIN TEST; SWEAT TEST; CHRONIC DISEASE; DRUG EFFECT; IMMUNOLOGY; SWEAT; SWEATING; URTICARIA;

ADULT; ANTI-ALLERGIC AGENTS; ANTIBODIES, MONOCLONAL; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN E; MUSCARINIC AGONISTS; PILOCARPINE; SKIN TESTS; SWEAT; SWEATING; URTICARIA;

EID: 68249146545     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2009.30.3237     Document Type: Article

References (24)

1. Moore-Robinson M, and Warin RP. Some clinical aspects of cholinergic urticaria. Br J Dermatol 80:794-799, 1968.
2. Wanderer AA, Bernstein IL, Goodman DL, et al. Part II: Chronic urticaria/angioedema (a practice parameter). Ann Asthma Allergy Immunol 85:532-544, 2000.
3. Hirschmann JV, Lawlor F, English JS, et al. Cholinergic urticaria: A clinical and histologic study. Arch Dermatol 123:462-467, 1987.
4. Soter NA, Wasserman SI, Austen KF, and McFadden ER. Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria. N Engl J Med 302:604-608, 1980.
5. Commens CA, and Greaves CA. Tests to establish the diagnosis in cholinergic urticaria. Br J Dermatol 98:47-51, 1978.
6. Gibson LE, and Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23:545-549, 1959.
7. Adachi J, Aoki T, and Yamatodani A. Demonstration of sweat allergy in cholinergic urticaria. J Dermatol Sci 7:142-149, 1994.
8. Baiardini I, Pasquuali M, Braido F, E et al. A new tool to evaluate the impact of chronic urticaria on the quality of life: Chronic urticaria quality of life questionnaire (CU0Q2oL). Allergy 60:1073-1078, 2005.
9. Duke WW. Urticaria caused specifically by the action of physical agents. JAMA 83:3-9, 1924.
10. Poon E, Seed PT, Greaves MW, and Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 140:667-671, 1999.
11. Sibbald RG. Physical urticaria. Dermatol Clin 3:57-69, 1984.
12. Khan DA. Chronic urticaria: Diagnosis and management. Allergy Asthma Proc 29:439-446, 2008.
13. Boguniewicz M. The autoimmune nature of chronic urticaria. Allergy Asthma Proc 29:433-438, 2008.
14. Fukunaga A, Bito T, Tsuru K, et al. Responsiveness to autologous serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol 116:397-402, 2005.
15. Boysen TC, Yanagawa S, and Sato K. A modified anaerobic method of sweat collection. J Appl Physiol 56:1302-1307, 1984.
16. Tanaka T, Ishii K, Suzuki H, et al. Cholinergic urticaria successfully treated by immunotherapy with partially purified sweat antigen [in Japanese]. Aerugi 56:54-57, 2007 (Abs).
17. Matthews CN, Kirby JD, James J, and Warin RP. Dermographism: Reduction in wheal size by chlorpheniramine and hydroxyzine. Br J Dermatol 88:279-282, 1973.
18. Wong E, Eftekhari N, Greaves MW, and Ward AM. Beneficial effects of danazol on symptoms and laboratory changes of cholinergic urticaria. Br J Dermatol 116:553-556, 1987.
19. Genetech, Inc. Omalizumab package insert. South San Francisco, CA. July 2008.
20. Fahy JV, Fleming HE, Wong HH, et al The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 155:1828-1834, 1997.
21. Spector SL, and Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 99:190-193, 2007.
22. Kaplan AP, Kusumam J, Maykut RJ, et al. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 122:569-573, 2008.
23. Gober LM, Sterba PM, Eckman JA, and Saini SS. Effect of Anti-IgE (Omalizumab) in chronic idiopathic urticaria (CIU) patients. J Allergy Clin Immunol 121:S147, 2008 (Abs).
24. Metz M, Bergmann P, Zuberbier T, and Maurer M. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 63:247-249, 2008.